Efficacy and tolerability of three different doses of oral pimecrolimus in the treatment of moderate to severe atopic dermatitis: a randomized controlled trial.
about
Topical pimecrolimus for eczemaClinical application of development of nonantibiotic macrolides that correct inflammation-driven immune dysfunction in inflammatory skin diseasesA systematic review of the safety of topical therapies for atopic dermatitis.What is the evidence base for atopic eczema treatments? A summary of published randomized controlled trials.Pimecrolimus 1% cream for oral erosive lichen planus: a 6-week randomized, double-blind, vehicle-controlled study with a 6-week open-label extension to assess efficacy and safety.Resolution of severe atopic dermatitis after tacrolimus withdrawal.
P2860
Efficacy and tolerability of three different doses of oral pimecrolimus in the treatment of moderate to severe atopic dermatitis: a randomized controlled trial.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Efficacy and tolerability of t ...... a randomized controlled trial.
@en
Efficacy and tolerability of t ...... a randomized controlled trial.
@nl
type
label
Efficacy and tolerability of t ...... a randomized controlled trial.
@en
Efficacy and tolerability of t ...... a randomized controlled trial.
@nl
prefLabel
Efficacy and tolerability of t ...... a randomized controlled trial.
@en
Efficacy and tolerability of t ...... a randomized controlled trial.
@nl
P2093
P2860
P1476
Efficacy and tolerability of t ...... a randomized controlled trial
@en
P2093
Multicentre Investigator Group
S Emady-Azar
P2860
P304
P356
10.1111/J.1365-2133.2005.06674.X
P407
P577
2005-06-01T00:00:00Z